Phase II study of weekly 4'-epidoxorubicin in patients with metastatic adenocarcinoma of the Cervix: An EORTC gynaecological cancer cooperative group study

1997-08-01

European Journal of Cancer , Volume 33 - Issue 9 p. 1513- 1515

Additional Metadata
Persistent URL	doi.org/10.1016/S0959-8049(97)00172-X, hdl.handle.net/1765/55528
Journal	European Journal of Cancer
Organisation	Department of Medical Oncology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	van der Burg, M., Bolis, G., Bakker, P., Curran, D., Sahmoud, T., & Vermorken, J. (1997). Phase II study of weekly 4'-epidoxorubicin in patients with metastatic adenocarcinoma of the Cervix: An EORTC gynaecological cancer cooperative group study. European Journal of Cancer, 33(9), 1513–1515. doi:10.1016/S0959-8049(97)00172-X

Publication